Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Vertex Pharmaceuticals, Inc (NASDAQ: VRTX) closed the day trading at $374.98 down -20.60% from the previous closing price of $472.27. In other words, the price has decreased by -$20.60 from its previous closing price. On the day, 10.72 million shares were traded. VRTX stock price reached its highest trading level at $414.8799 during the session, while it also had its lowest trading level at $373.205.
Ratios:
For a better understanding of VRTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 2.52. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
On May 06, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $503.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 21 ’25 when LR 2019 Benefit Trust bought 170 shares for $447.18 per share.
SR 2019 Benefit Trust bought 170 shares of VRTX for $76,021 on May 21 ’25. On May 15 ’25, another insider, ALTSHULER DAVID, who serves as the EVP, Chief Scientific Officer of the company, sold 52 shares for $424.69 each. As a result, the insider received 22,084 and left with 23,281 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRTX now has a Market Capitalization of 96107380736 and an Enterprise Value of 91251974144. As of this moment, Vertex’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.80, and their Forward P/E ratio for the next fiscal year is 18.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.47 while its Price-to-Book (P/B) ratio in mrq is 5.60. Its current Enterprise Value per Revenue stands at 7.991 whereas that against EBITDA is 19.018.
Stock Price History:
The Beta on a monthly basis for VRTX is 0.45, which has changed by -0.1951319 over the last 52 weeks, in comparison to a change of 0.21149921 over the same period for the S&P500. Over the past 52 weeks, VRTX has reached a high of $519.88, while it has fallen to a 52-week low of $377.85. The 50-Day Moving Average of the stock is -17.51%, while the 200-Day Moving Average is calculated to be -19.03%.
Shares Statistics:
Over the past 3-months, VRTX traded about 1.53M shares per day on average, while over the past 10 days, VRTX traded about 2363260 shares per day. A total of 256.30M shares are outstanding, with a floating share count of 256.08M. Insiders hold about 0.28% of the company’s shares, while institutions hold 95.23% stake in the company. Shares short for VRTX as of 1752537600 were 4188160 with a Short Ratio of 2.73, compared to 1749772800 on 4034849. Therefore, it implies a Short% of Shares Outstanding of 4188160 and a Short% of Float of 1.8399999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
